Disclosed transactions
47 reported transactions
Amounts are the ranges in the filing. Purchases and sales are disclosures, not a statement of current holdings.
Tina Smith
Democrat — D–MN · U.S. Senate · serving since 2018 · Senate Committee on Indian Affairs, Senate Committee on Agriculture, Nutrition, and Forestry, Senate Committee on Banking, Housing, and Urban Affairs, Senate Committee on Finance · member ID S001203Amounts are statutory ranges; totals on this page are therefore ranges too. Amount ranges ↗
- Disclosures
- 47 26 filings · 0 paper · retained
- Net flow · 12m
- −$2.0M to −$800K purchases minus sales · statutory ranges, an interval
- Distinct tickers
- 19 across every disclosed row
- Late filings
- 2 filed past the 45-day window
Flows from periodic transaction reports · House Clerk + Senate eFD · statutory ranges · every row retains its receipt
Disclosed flow by quarter
bar = [min, max] of bucket sums · derived ·§flow range = sum of statutory bucket bounds — an interval, not an estimate of value; derived by Public Filings from the disclosed ranges24Q4
25Q1
25Q2
25Q3
25Q4
26Q1
26Q2
26Q3
how this chart is drawn ·§gaps are gaps — no interpolation · y from $0 · no midpoints — bar spans the disclosed bounds · source: House Clerk + Senate eFD
Disclosed flow by quarter. 24Q4: purchases $50K–$100K, no sales; 25Q1: no purchases, sales $200K–$500K; 25Q2: no purchases, no sales; 25Q3: no purchases, no sales; 25Q4: no purchases, sales $100K–$250K; 26Q1: no purchases, sales $300K–$700K; 26Q2: no purchases, sales $400K–$1M; 26Q3: no purchases, no sales
Net disclosed flow by ticker
flows, not holdings ·§PTRs are flows, not holdings — this table nets disclosed flow intervals; it is NOT a portfolio and cannot become one without the member's annual FD report · 6 rows disclose no ticker and are outside this tableALL DISCLOSED HISTORY · net range| Net | Ticker | Issuer | Buy ◂ ▸ Sellnet disclosed flow = sum of purchase bucket bounds minus sum of sale bucket bounds, as a net range net = [pL−sU, pU−sL]. A side with no rows has summed zero — a fact, not an absence. A row with any wholly-undisclosed amount on either side is not rankable and sits in the labeled bucket below the ranked rows, never coerced to zeronet disclosed flow = sum of purchase bucket bounds minus sum of sale bucket bounds, as a net range net = [pL−sU, pU−sL]. A side with no rows has summed zero — a fact, not an absence. A row with any wholly-undisclosed amount on either side is not rankable and sits in the labeled bucket below the ranked rows, never coerced to zero | Buys | Sells | Net range ·§net disclosed flow = sum of purchase bucket bounds minus sum of sale bucket bounds, as a net range net = [pL−sU, pU−sL]. A side with no rows has summed zero — a fact, not an absence. A row with any wholly-undisclosed amount on either side is not rankable and sits in the labeled bucket below the ranked rows, never coerced to zero | Last traded | 13FInstitutional overlap is not available in this build. |
|---|---|---|---|---|---|---|---|---|
| BUY | AORT | Artivion, Inc. Common Stock | Purchases $150K–$300K; sales — | 3 | 0 | $150K to $300K net accumulation | 2023-11-16 | — |
| BUY | MSTY.PA | Mainstay Medical International plc | Purchases $100K–$200K; sales — | 2 | 0 | $100K to $200K net accumulation≈ | 2018-10-30 | — |
| MIXED | TCF HBAN | TCF Financial Corporation - Common Stock (Exchanged) Huntington Bancshares Incorporated - Common Stock (Received) | Purchases —; sales — | 0 | 0 | $0 | 2021-06-09 | — |
| SELL | ENTL | Entellus Medical, Inc. | Purchases —; sales $50K–$100K | 0 | 1 | −$100K to −$50.0K net disposal | 2018-01-05 | — |
| SELL | MMM | 3M Company Common Stock | Purchases —; sales $50K–$100K | 0 | 1 | −$100K to −$50.0K net disposal≈ | 2026-03-31 | — |
| SELL | CSII | Cardiovascular Systems, Inc. - Common Stock | Purchases —; sales $100K–$200K | 0 | 2 | −$200K to −$100K net disposal≈ | 2023-04-05 | — |
| SELL | GIS | General Mills, Inc. Common Stock | Purchases —; sales $100K–$250K | 0 | 1 | −$250K to −$100K net disposal≈ | 2025-02-11 | — |
| SELL | HBAN | Huntington Bancshares Incorporated - Common Stock | Purchases —; sales $100K–$250K | 0 | 1 | −$250K to −$100K net disposal≈ | 2025-11-21 | — |
| SELL | IIN | IntriCon Corporation | Purchases —; sales $100K–$250K | 0 | 1 | −$250K to −$100K net disposal≈ | 2018-07-26 | — |
| SELL | MDT | Medtronic plc. Ordinary Shares | Purchases —; sales $100K–$250K | 0 | 1 | −$250K to −$100K net disposal≈ | 2023-04-05 | — |
| SELL | NEE | Nextera Energy | Purchases —; sales $100K–$250K | 0 | 1 | −$250K to −$100K net disposal≈ | 2024-04-04 | — |
| SELL | PEP | PepsiCo, Inc. - Common Stock | Purchases —; sales $100K–$250K | 0 | 1 | −$250K to −$100K net disposal≈ | 2025-02-11 | — |
| MIXED | TCMD | Tactile Systems Technology Inc | Purchases $150K–$350K; sales $200K–$500K | 2 | 2 | −$350K to $150K≈ | 2024-11-12 | — |
| SELL | CGNT | Cogentix Medical, Inc. | Purchases —; sales $131K–$365K | 0 | 4 | −$365K to −$131K net disposal≈ | 2018-04-12 | — |
| SELL | BRK.B | Berkshire Hathaway Inc. New Common Stock | Purchases —; sales $200K–$500K | 0 | 2 | −$500K to −$200K net disposal≈ | 2026-03-31 | — |
| SELL | ABT | Abbott Laboratories | Purchases —; sales $250K–$500K | 0 | 1 | −$500K to −$250K net disposal≈ | 2019-04-09 | — |
| SELL | CUTR | Cutera, Inc. | Purchases —; sales $351K–$765K | 0 | 3 | −$765K to −$351K net disposal≈ | 2018-08-30 | — |
| SELL | DXCM | DexCom, Inc. - Common Stock | Purchases —; sales $450K–$1M | 0 | 3 | −$1.0M to −$450K net disposal≈ | 2026-05-07 | — |
| SELL | PODD | Insulet Corporation - Common Stock | Purchases —; sales $965K–$2.2M | 0 | 8 | −$2.2M to −$965K net disposal≈ | 2026-05-07 | — |
Trading profile
VS SENATE MEDIAN · TICK = MEDIAN · 68 MEMBERS- Filing lag (median)median days between trade date and filing date, over rows that disclose both
- +14dfaster than chamber — median +28d
- Rows per filingmachine-readable transaction rows per distinct source filing
- 1.8below median — median 2.9
- Share ≤ $15K bracket
- 6%larger lots — median 60%
- Buy share of rows
- 26%below median — median 49%
- Self-owned share
- 0%family accounts — median 28%
filings incl. 0 paper: 26distinct default-view filings for this member, including paper (needs-OCR) filings that carry zero machine-readable rows · transactions: 47 · disclosed flow · trailing 12m: $800K–$2Msum of statutory bucket bounds over the trailing 12 months — an interval, not an estimate of value · median lag: +14dmedian days between trade date and filing date, over rows that disclose both · late filings: 2rows filed past the STOCK Act's 45-day window
Medians are per member across the 68 Senate members with disclosed rows in this build — one observation each, so a high-volume filer does not become the chamber. Statistics describe the filing record, never intent.
Sector mix
taxonomy v1 · SIC as of 2026-09-14| Sector | Trades | Flow range |
|---|---|---|
| manufacturing | 23 | $2.5M–$5.7M |
| services | 4 | $131K–$365K |
| finance-insurance-realestate | 1 | $100K–$250K |
| transport-utilities | 1 | $100K–$250K |
| ticker not resolved to an issuer coverage | 12 | $1M–$2.3M |
| no ticker disclosed coverage | 6 | $111K–$315K |
Sector from SEC SIC codesSector comes from SEC EDGAR SIC codes through the site's own taxonomy; rows without a sector are listed as coverage, never folded into a sector.
Recent disclosures and committee context
Largest recent disclosures
trailing 90d · lower boundNo rankable disclosures in the trailing 90 days.
Committees · jurisdiction overlap
membership snapshot 2026-09-14 · jurisdiction mapping v1Serves on: Senate Committee on Indian Affairs · Senate Committee on Agriculture, Nutrition, and Forestry · Senate Committee on Banking, Housing, and Urban Affairs · Senate Committee on Finance
| Traded | Ticker | Sector | Committee | Src |
|---|---|---|---|---|
| 2025-11-21 | HBAN | finance-insurance-realestate | Senate Committee on Banking, Housing, and Urban Affairs |
21 trades predate the membership snapshot's validity window — unanswerable, not cleared · 7 trades touch committees outside the jurisdiction mapping (SLIA, SSFI) — unanswerable there, not cleared
A jurisdiction overlap is context, not an accusation: it establishes and implies no legal, ethical, or causal conflict. It states only that the issuer's sector falls within a committee this member sat on as of the trade date, per the sources and mapping versions shown.
All disclosed transactions
47 rows · filed date desc · as of 2026-09-14 13:21 UTC| Kind | Ticker | Asset | OwnerFilings under this member include transactions by spouse (SP), dependent children (DC), and joint accounts (JT) — the STOCK Act does not distinguish who directed a trade. Owner codes ↗ | Range | Amount range | Traded → Filed | Source |
|---|---|---|---|---|---|---|---|
| Sale | PODD | Insulet Corporation - Common Stock | · SP (spouse-owned) | $100K–$250K | Traded → Filed +3d | ||
| Sale | DXCM | DexCom, Inc. - Common Stock | · SP (spouse-owned) | $100K–$250K | Traded → Filed +3d | ||
| Sale | DXCM | DexCom, Inc. - Common Stock | · partial · SP (partial sale, spouse-owned) | $100K–$250K | Traded → Filed +11d | ||
| Sale | PODD | Insulet Corporation - Common Stock | · partial · SP (partial sale, spouse-owned) | $100K–$250K | Traded → Filed +11d | ||
| Sale | BRK.B | Berkshire Hathaway Inc. New Common Stock | · SP (spouse-owned) | $100K–$250K | Traded → Filed +2d | ||
| Sale | MMM | 3M Company Common Stock | · SP (spouse-owned) | $50K–$100K | Traded → Filed +2d | ||
| Sale | BRK.B | Berkshire Hathaway Cl B | · partial · SP (partial sale, spouse-owned) | $100K–$250K | Traded → Filed +3d | ||
| Sale | — | MRSH - Marsh & McLennan Companies, Inc. Common Stock | · SP (spouse-owned) | $50K–$100K | no ticker | Traded → Filed +3d | |
| Sale | HBAN | Huntington Bancshares Incorporated - Common Stock | · SP (spouse-owned) | $100K–$250K | Traded → Filed +5d | ||
| Sale | GIS | General Mills, Inc. Common Stock | · SP (spouse-owned) | $100K–$250K | Traded → Filed +36d | ||
| Sale | PEP | PepsiCo, Inc. - Common Stock | · SP (spouse-owned) | $100K–$250K | Traded → Filed +36d | ||
| Purchase | TCMD | Tactile Systems Technology Inc | · SP (spouse-owned) | $50K–$100K | Traded → Filed +9d | ||
| Sale | PODD | Insulet Corporation - Common Stock | · partial · SP (partial sale, spouse-owned) | $50K–$100K | Traded → Filed +15d | ||
| Sale | NEE | Nextera Energy | · partial · SP (partial sale, spouse-owned) | $100K–$250K | Traded → Filed +15d | ||
| Purchase | AORT | Artivion, Inc. Common Stock | · SP (spouse-owned) | $50K–$100K | Traded → Filed +4d | ||
| Purchase | AORT | Artivion, Inc. Common Stock | · SP (spouse-owned) | $50K–$100K | Traded → Filed +10d | ||
| Purchase | TCMD | Tactile Systems Technology, Inc. - Common Stock | · SP (spouse-owned) | $100K–$250K | Traded → Filed +12d | ||
| Sale | CSII | Cardiovascular Systems, Inc. - Common Stock | · SP (spouse-owned) | $50K–$100K | Traded → Filed +14d | ||
| Sale | MDT | Medtronic plc. Ordinary Shares | · SP (spouse-owned) | $100K–$250K | Traded → Filed +14d | ||
| Sale | CSII | Cardiovascular Systems, Inc. - Common Stock | · SP (spouse-owned) | $50K–$100K | Traded → Filed +14d | ||
| Purchase | AORT | Artivion, Inc. Common Stock | · SP (spouse-owned) | $50K–$100K | Traded → Filed +24d | ||
| Exchange | TCF HBAN | TCF Financial Corporation - Common Stock (Exchanged) Huntington Bancshares Incorporated - Common Stock (Received) | · SP (spouse-owned) | $100K–$250K | Traded → Filed LATE·341d | ||
| Purchase | — | Northern Lakes Capital IV, LP | · SP (spouse-owned) | $15K–$50K | no ticker | Traded → Filed +16d | |
| Purchase | — | Surgical Information Sciences | · SP (spouse-owned) | $1K–$15K | no ticker | Traded → Filed +29d | |
| Purchase | — | Surgical Information Sciences | · SP (spouse-owned) | $15K–$50K | no ticker | Traded → Filed +30d | |
| Sale | DXCM | DexCom, Inc. | · partial · SP (partial sale, spouse-owned) | $250K–$500K | Traded → Filed +30d | ||
| Sale | PODD | Insulet Corporation | · partial · SP (partial sale, spouse-owned) | $250K–$500K | Traded → Filed +30d | ||
| Purchase | — | Surgical Information Sciences | · SP (spouse-owned) | $15K–$50K | no ticker | Traded → Filed +9d | |
| Purchase | — | Surgical Information Sciences | · SP (spouse-owned) | $15K–$50K | no ticker | Traded → Filed LATE·482d | |
| Sale | ABT | Abbott Laboratories | · JT (jointly owned) | $250K–$500K | Traded → Filed +15d | ||
| Purchase | MSTY.PA | Mainstay Medical International plc | · SP (spouse-owned) | $50K–$100K | Traded → Filed +15d | ||
| Purchase | MSTY.PA | Mainstay Medical International plc | · SP (spouse-owned) | $50K–$100K | Traded → Filed +16d | ||
| Sale | PODD | Insulet Corporation | · partial · SP (partial sale, spouse-owned) | $15K–$50K | Traded → Filed +20d | ||
| Sale | CUTR | Cutera, Inc. | · SP (spouse-owned) | $100K–$250K | Traded → Filed +20d | ||
| Sale | PODD | Insulet Corporation | · JT (jointly owned) | $250K–$500K | Traded → Filed +20d | ||
| Sale | CUTR | Cutera, Inc. | · SP (spouse-owned) | $1K–$15K | Traded → Filed +20d | ||
| Sale | IIN | IntriCon Corporation | · partial · SP (partial sale, spouse-owned) | $100K–$250K | Traded → Filed +26d | ||
| Sale | TCMD | Tactile Systems Technology, Inc. | · SP (spouse-owned) | $100K–$250K | Traded → Filed +10d | ||
| Sale | TCMD | Tactile Systems Technology, Inc. | · partial · SP (partial sale, spouse-owned) | $100K–$250K | Traded → Filed +10d | ||
| Sale | PODD | Insulet Corporation | · partial · SP (partial sale, spouse-owned) | $100K–$250K | Traded → Filed +10d | ||
| Sale | CGNT | Cogentix Medical, Inc. | · SP (spouse-owned) | $100K–$250K | Traded → Filed +8d | ||
| Sale | CGNT | Cogentix Medical, Inc. | · partial · SP (partial sale, spouse-owned) | $15K–$50K | Traded → Filed +8d | ||
| Sale | CGNT | Cogentix Medical, Inc. | · partial · SP (partial sale, spouse-owned) | $15K–$50K | Traded → Filed +10d | ||
| Sale | CGNT | Cogentix Medical, Inc. | · partial · SP (partial sale, spouse-owned) | $1K–$15K | Traded → Filed +11d | ||
| Sale | PODD | Insulet Corporation | · partial · JT (partial sale, jointly owned) | $100K–$250K | Traded → Filed +4d | ||
| Sale | CUTR | Cutera, Inc. | · partial · SP (partial sale, spouse-owned) | $250K–$500K | Traded → Filed +13d | ||
| Sale | ENTL | Entellus Medical, Inc. | · JT (jointly owned) | $50K–$100K | Traded → Filed +24d |
Amended filings show the latest versionEach row is the latest version of its filing: an amendment replaces the original it supersedes, and the original stays in the published record. · what's excluded ↗
1–47 of 47 transactions
Filing history
SOURCE REPORTS · FILED ↓| Filed | Rows | Receipt |
|---|---|---|
| 2026-05-10 | 4 | |
| 2026-04-02 | 2 | |
| 2026-01-30 | 2 | |
| 2025-11-26 | 1 | |
| 2025-03-19 | 2 | |
| 2024-11-21 | 1 | |
| 2024-04-19 | 2 | |
| 2023-11-20 | 3 | |
| 2023-04-19 | 3 | |
| 2022-10-17 | 1 | |
| 2022-05-16 | 1 | |
| 2022-04-20 | 1 | |
| 2021-05-10 | 1 | |
| 2020-05-31 | 1 | |
| 2020-04-16 | 2 | |
| 2019-10-25 | 1 | |
| 2019-10-23 | 1 | |
| 2019-04-24 | 1 | |
| 2018-11-14 | 2 | |
| 2018-09-19 | 4 | |
| 2018-08-21 | 1 | |
| 2018-06-11 | 3 | |
| 2018-04-20 | 3 | |
| 2018-04-09 | 1 | |
| 2018-03-06 | 1 | |
| 2018-01-29 | 2 |
Signals
window 2026-06-16 → 2026-09-14No signals for this member in the retained window — a computed answer over the rules on /signals, not an absence of coverage.
PLANNED annual holdings · 13F overlap
Additional disclosure analysis
Most-disclosed tickers
trailing 24m| Ticker | Trades | Flow range ·§flow range = sum of statutory bucket bounds — an interval, not an estimate of value; derived by Public Filings from the disclosed ranges | Last |
|---|---|---|---|
| BRK.B | 2 | $200K–$500K§ | 2026-03 |
| DXCM | 2 | $200K–$500K§ | 2026-05 |
| PODD | 2 | $200K–$500K§ | 2026-05 |
| GIS | 1 | $100K–$250K§ | 2025-02 |
| HBAN | 1 | $100K–$250K§ | 2025-11 |
| MMM | 1 | $50K–$100K§ | 2026-03 |
Reporting window
Published 2026-09-14
Trade date and filing date are retained separately. Late and unparseable records stay identified in the data.
Holdings coverage
Annual holdings are not in this view
Periodic transaction reports do not establish a portfolio. Annual holdings and reconciliation require annual financial-disclosure records.